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Abstract
Aim. In this study, we investigated in people suffering from alcohol use disorder (AUD) 
with or without dual diagnosis (concomitant psychiatric disability) how they feel their 
dependence condition. We predicted that AUD people with a dual diagnosis could feel 
potentiated their addiction. 
Methods. Alcohol habits and psychiatric conditions of 183 AUD men and 62 AUD 
women were measured by using the DSM-5, the severity of alcohol dependence ques-
tionnaire (SADQ), the alcohol anamnesis and psychiatric examination by the symptom 
check list 90-R (SCL-90-R). 
Results. We have shown that alcohol drinking does not correlate with both psychiatric 
examination and self-reported psychopathology. SADQ shows that severe alcohol de-
pendence correlates with highest psychiatric symptoms and with the levels of alcohol 
consumption. 
Conclusions. This finding suggests that high SADQ scores may represent a tool to early 
disclose only patients with dual diagnosis. SADQ may provide information to address 
pharmacological interventions because revealing aspects of the dark side of addiction 
potentiated by AUD associated psychopathology.
INTRODUCTION
People suffering from Alcohol Use Disorder (AUD) 
frequently show behavioral impairments and related 
psychiatric disruptions (dual diagnosis) [1-12], In the 
early studies of the Cloninger group, two subtypes of 
alcoholism have been described. The type I, affecting 
both men and women, could have genetic or environ-
mental bases, usually starting at an early age, and caus-
ing either mild or severe alcohol dependence [13]. The 
type I was characterized by loss of control over drink-
ing, binge drinking, guilt about drinking and progressive 
severity of alcohol abuse. The personality traits of type 
I were high harm avoidance and low novelty seeking, 
the person drinks to relieve anxiety. Instead, the type 
II is primarily genetic [5] affects men more often than 
women, and mainly sons of male alcoholics, the alcohol 
problems appear before age 25 and often begins during 
adolescence or early adulthood. Type II is characterized 
by the inability to abstain from alcohol. Type II is also 
associated with criminal behavior and with a history of 
antisocial acts. Relatively to personality traits, type II is 
characterized by high novelty seeking, person drinks to 
induce euphoria. Psychopathological dysfunction and 
sociopathy and often coexist in type II. In fact, type II 
alcoholism has more emotional regulation difficulties 
and a lot of social problems, than type 1 alcoholism, that 
can contribute to developing psychiatric disorders [14].
Depression, anxiety and personality disorders are of-
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ten associated with alcoholism and contribute to craving 
and relapse [2, 6, 15-21]. AUD people with dual diag-
nosis are reported to be high users of the health care 
system [22] and to have a more severe course of alcohol 
dependence [23, 24] than AUD people without a dual 
diagnosis [17, 25]. Indeed, the comorbid condition of 
psychiatric impairments and AUD may predict both re-
lapsing shorter time and increasing treatment drop-out 
[26-28]. Dual diagnosis and alcohol addiction severity 
are crucial at-risk factors for relapse and drop-out events 
[29-31], but only a few studies concurrently investigated 
their related conditions. Such studies used self-admin-
istered questionnaires as the symptom check list 90-R 
(SCL-90-R) [32] and the severity of alcohol dependence 
questionnaire (SADQ) [33] to assess psychiatric con-
dition and alcohol addiction magnitude. However, for 
assessing the levels of alcohol addiction previous studies 
[34-36] mostly investigated only the SADQ total score 
but without considering the analysis of the questionnaire 
subscales. Such analyses may provide subtle indications 
to disclose that certain drinking problem domains are 
closely related to crucial aspects of dependence [37, 38]. 
Thus, the aim and novelty of this study was to analyze 
in a cohort of about 250 AUD people the relationship 
between psychiatric diseases and the severity of alcohol 
dependence using not only the behavioral responses 
to self-administered questionnaires (SADQ and SCL-
90-R) but also the clinical examinations carried out by 
psychiatrists and physicians with long-lasting expertise 
in psychiatry and alcohol addiction by using the DSM-
5 criteria and ad hoc tools for measuring real drinking 
habits as life drink history (LDH) and time line follow 
back (TLFB) according to the standardized methodol-
ogy of the Italian guidelines for the treatment of alcohol 
addiction [39, 40]. We predict that AUD people with 
dual diagnosis could feel potentiated their addiction. 
Potential gender differences were also investigated.
MATERIALS AND METHODS
AUD people recruitment
AUD participants were recruited in the Latium Re-
gion Alcohol Referral Center at Policlinico Umberto I, 
Sapienza University Hospital, in Rome, Italy during a 
15 days-long day-hospital period. All participants met 
the DSM-5 criteria for AUD.  According to the indica-
tions of the National Institute on Alcohol Abuse and 
Alcoholism (NIAAA) we considered “at-risk” drinkers 
people drinking up to 4 drinks per day or 14 per week 
for men (in Italy 1 drink = 12 g), more than 3 drinks per 
day or 7 drinks per week for women (in Italy 1 drink = 
12 g). NIAAA defines heavy drinking as 5 or more stan-
dard drinks in a day for a man and 4 or more standard 
drinks in a day for a woman [41]. AUD people enrolled 
in the study were 245 (Table 1), 74.6% (n = 183) of them 
were men and their mean age was 47.20 ± 10.8 years 
and 62 (25.4%) women (48.15 ± 10.28 age in years). 
The 81.6% of AUD people were Italians, the 39.8% 
were married and 31% were single. The mean age of 
onset of alcohol problems was 28.99 ± 10.96 years. The 
AUD group reported an average of 17.95 ± 12.88 years 
of problem drinking and an average of 13.99 ± 10.86 
drinks per day during the month prior to the admission 
to the treatment unit. 40% of the cases had completed 
at least 8 years of schooling.
Patients were divided into two groups: AUD patients 
without a dual diagnosis as referred to the SCL-90-R 
and as evaluated by the psychiatrist examination (n = 
74; 58 men and 16 women) and AUD patients with a 
dual diagnosis (n = 171; 125 men and 46 women). Such 
differences between the number of recruited men and 
women may be explained to the fact that AUD men 
tend to ask for help more often than AUD women [42] 
even though the same women could show a more seri-
ous psychiatric condition [43].
The 171 AUD patients with dual diagnosis present-
Table 1
Description of the two groups of AUD patients with and without dual diagnosis divided for gender, enrolled in the study. Data are 
expressed as means ± SD, as median or as percentage. CAD = cumulative abstinence duration; SES = socio-economic status (1 up 
to 5000 euro per year; 2 from 5000 to 10 000 euro; 3 from 10 000 to 20 000; 4 over 20 000). According to NIAAA for men alcohol 
risk consumption begins with more than 4 drinks on any single day and more than 14 drinks per week. 1 drink = 12 g of alcohol 
in Italy. For the Educational Level, 1 represents no scholastic degree, 2 Primary School (8 years of compulsory formal education), 3 
Secondary School (5 years of formal education), 4 University degree
AUD patient without dual diagnoses AUD patient with dual diagnoses
Men (n = 58) Women (n = 16) Men (n = 125) Women (n = 46)
Age 48.40 ± 9.76 49.79 ± 10.25 46.65 ± 11.25 47.61 ± 10.35
Educational level [1 low – 4 high] 2.11 ± 0.49 2.33 ± 0.62 2.30 ± 0.69 2.44 ± 0.62
SES [1 low – 4 high] 2.24 ± 0.31 2.43 ± 0.18 2.34 ± 0.35 2.28 ± 0.28
Age of first consumption 28.97 ± 10.78 31.38 ± 9.26 26.89 ± 10.68 32.93 ± 11.58
Years of critical consumption 19.52 ± 14.01 16.50 ± 10.98 19.20 ± 13.26 14.23 ± 11.09
Alcohol preference (%) 
wine
beer
spirit
50.3
30.9
15.8
44.1
28.5
25.8
52.6
31.6
16.4
44.6
29.4
27.4
Abstinence days before the test [CAD] 5.63 ± 8.976 9.33 ± 11.672 5.11 ± 7.964 5.64 ± 7.312
Previous use of psychoactive substances [%] 30.9 17.1 32.1 16.3
Smoking [daily number of cigarettes] 17.8 ± 11.76 16.43 ± 11.98 17.1 ± 11.95 16.75 ± 12.78
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ed different psychiatric conditions: most of them, the 
49.7%, present a bipolar disorder followed by the 28.8% 
that present a mood disorder, the 8.9% present an anxi-
ety disorder, the 8.8% present a personality disorder. 
Only the 2.3% present psychotic symptomatology and 
the 1.5% present adjustment disorders.
Table 1 shows also the differences in the sociodemo-
graphic and alcohol variables between the two groups 
of AUD patients with and without a dual diagnosis for 
gender.
Exclusion criteria for all participants included history 
of head injury, loss of consciousness, history of organic 
mental disorder, present assumption of psychoactive 
drugs as cocaine, opioids, amphetamine, other recre-
ational drugs, anxiolytics, euphoriants, antipsychotics, 
barbiturates, antidepressants, hallucinogens-data based 
on urine toxicology), seizure disorder or central nervous 
system diseases and no sign of hypertension at the time 
of recruitment. Breath alcohol level was measured by 
using Alcoscan AL7000. During the 15-day long hos-
pitalization period, alcohol consumption was also ana-
lyzed by the presence of Ethylglucoronide in the urine 
[44]. Psychiatric examination and self-administered 
interviews were carried out between day 7 and day 8 
of the two weeks day-hospital period. The study was 
approved by the University Hospital ethical committee 
and informed consent was signed by each participant 
and all the study procedures were in accordance with 
the Helsinki Declaration of 1975, as revised in 1983, 
for human experimentation. The clinical diagnosis for 
dual diagnosis and the clinical diagnosis for alcohol ad-
diction were carried out by different specialists unaware 
of the final group assignment of the patients according 
to the psychological and cognitive assessments by self-
report questionnaires (see below).
Clinical assessment for a dual diagnosis
Psychiatric examination by DSM-5 criteria for di-
mensional assessment and diagnosis of mental disorders 
(based on descriptions, symptoms and other criteria for 
diagnosing mental disorders) [45] in AUD people was 
carried out to assess the presence of psychiatric dis-
orders. A psychiatric examination was carried out be-
tween day 7 and day 8 of the 15-day long day-hospital 
period for a first diagnostic orienting as stated before. 
Then, the psychiatrist, when the patients concluded the 
detox period, performs a second evaluation to confirm 
or modify the diagnosis (between day 15 and 20 after 
the end of the day-hospital). The last diagnosis was 
used to confirm the classification of the two groups of 
AUD patients without and with dual diagnosis. 
Clinical assessment for alcohol dependence
AUD magnitude and the lifetime alcohol consump-
tion were assessed by clinicians by using LDH, TLFB 
and the DSM-5 Severity Scale for Alcohol Use Disorder.
LDH [46] is a retrospective, interview-based proce-
dure, used to identify patterns of alcohol use, abuse, 
and dependence beginning with the onset of regular 
drinking and ending with the individual’s current drink-
ing pattern [46-48]. 
TLFB [49, 50] is used as a clinical and research tool 
to obtain a variety of quantitative estimates of alcohol 
and other drugs’ use in the last month.
Both LDH and TLFB were administered by physi-
cians with a long-lasting experience on alcohol addic-
tion after the disappearing of the withdrawal symptoms 
according to a set of specific evidence, such as elevated 
blood pressure, tachycardia, tremor, sweating and no al-
cohol presence (see also the above-described methods). 
The DSM-5 diagnostic criteria for alcohol use disor-
der [45] is used to designate mild (2-3), moderate (4-5), 
and severe (≥ 6) dependence. The AUD diagnosis was 
determined by analysing the number of AUD criteria of 
the past 12 months. DSM-5 defined AUD symptoms 
included: 1) tolerance, 2) withdrawal, 3) substance tak-
en in larger amounts/longer period than intended, 4) 
persistent desire or unsuccessful attempts to decrease/
control use, 5) a great deal of time spent obtaining, us-
ing or recovering from effects of alcohol, 6) social, occu-
pational, or recreational activities given up or reduced 
because of use, 7) use despite knowledge of physical or 
psychological problems caused or exacerbated by use, 
8) recurrent failure to fulfil major role obligations, 9) re-
current use in hazardous situations, 10) craving/strong 
desire to use the substance, 11) continued use despite 
social/interpersonal problems. 
Psychological and cognitive assessments  
by self-report questionnaires
Self-report measures were carried out to investigate 
the psychological and cognitive functioning and the 
severity of the dependence. AUD people provided dif-
ferent self-report assessments under the supervision of 
a psychologist with a long-lasting training in alcohol ad-
diction. In particular, we analysed the mini-mental state 
examination (MMSE), the vocabulary subtest of the 
WAIS-R, the SCL-90-R and the SADQ.
The MMSE [51] is a brief 30-point questionnaire, 
the most frequently used assessment methods for the 
estimation of cognitive function, and it has been shown 
to have adequate reliability and validity to screen for 
cognitive impairment. The raw score needs to be cor-
rected for educational attainment and age [52]. 
The vocabulary subtest of the WAIS-R [53] is con-
sidered to be one of the best indicators of general in-
telligence and is used to assess the verbal intellectual 
functioning in clinical practice. The WAIS-R vocabulary 
subtest consists of the meaning definition of 40 words.
The SCL-90-R [54] is a 90-item self-report symptom 
inventory designed to reflect psychological symptom 
patterns of psychiatric and medical patients. Each item 
of the questionnaire is rated on a 5-point scale of dis-
tress from 0 (none) to 4 (extreme). The SCL-90-R used 
in the present investigation consists of the following 
nine primary symptom dimensions and a global sever-
ity index (GSI): somatization (SOM, which reflects dis-
tress arising from bodily perceptions), obsessive-com-
pulsive (OC, which reflects obsessions-compulsions 
symptoms), interpersonal sensitivity (IS, which reflects 
feelings of personal inadequacy and inferiority in com-
parison with others), depression (DEP, which reflects 
depressive symptoms, as well as lack of motivation), 
anxiety (ANX, which reflects anxiety symptoms and ten-
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sion), hostility (HOS, which reflects thoughts, feelings, 
or actions that are characteristic of negative affective 
states of anger, aggression, irritability, rage, and resent-
ment), phobic anxiety (PHO, which reflects symptoms 
of persistent fears as responses to specific conditions), 
paranoid ideation (PAR, which reflects symptoms of 
projective thinking, hostility, suspiciousness, and fear 
of loss of autonomy), and psychoticism (PSY, which 
reflects a broad range of symptoms from mild interper-
sonal alienation to dramatic evidence of psychosis) [32, 
55, 56]. The SCL-90-R presents three global indices: 
global severity index (GSI) designed to measure overall 
psychological distress; positive symptom distress index 
(PSDI) designed to measure the intensity of symptoms 
and positive symptom total (PST) reporting the num-
ber of self-reported symptoms. However, the GSI is the 
single best indicator of the current level or depth of an 
individual’s disorder. It combines information concern-
ing the number of symptoms reported with the inten-
sity of perceived distress. The SCL-90-R takes between 
12 and 20 min to complete. The internal consistency 
coefficient a values for the nine symptom dimensions 
ranged from a low of 0.77 for psychoticism to a high 
of 0.90 for depression. In an Italian study, the internal 
coherence for all subscales showed alpha values ranging 
between 0.70 and 0.96 [57]. Based on the Italian ver-
sion of the SCL-90-R [58] the T cut-off level used in the 
present study to discriminate AUD people with dual 
diagnosis vs AUD without dual diagnosis people was 
set to T ≥ 55 in the GSI score. The SCL-90-R was com-
pleted in the presence of psychologists who provided 
clarifications when necessary.
The SADQ [33, 59, 60] is a short, easy-to-complete, 
self-administered, 20-items questionnaire designed to 
measure the severity of dependence on alcohol as for-
mulated by Edwards & Gross [61]. There are five sub-
scales each including four items: physical withdrawal, 
affective withdrawal, withdrawal relief drinking, alco-
hol consumption, and rapidity of reinstatement. The 
physical withdrawal, withdrawal relief drinking, alcohol 
consumption, and rapidity of reinstatement subscales 
are specially focused on the physical aspects of alcohol 
dependence while the affective withdrawal subscales 
refers to affective aspects of alcohol dependence. Each 
item is scored on a 4-point scale, ranging from almost 
never to nearly always, resulting in a corresponding 
score of 0 to 3. Thus, the total maximum score possible 
is 60 and the minimum is 0 [33, 62]. A score greater 
than 30 indicates severe alcohol dependence; scores 
ranging from 16 and 30 indicate the presence of mod-
erate alcohol dependence. Above 16 a mild dependence 
was assessed [63].
Statistical analysis 
Data were analyzed using SPSS. Descriptive analyses 
were conducted to evaluate the characteristics of the 
enrolled participants. TLFB, LDH, SCL-90-R, SADQ 
and DSM-5 data were analyzed by two-way ANOVA 
to determine differences between AUD people with or 
without a dual diagnosis. Gender differences were also 
considered as a main factor. Post-hoc comparisons were 
carried out by using the LSD testing. Pearson bivari-
ate correlations were calculated between SADQ scores 
and psychopathological indicators and alcohol variables 
(years of alcohol abuse, the age of onset, total alcoholic 
units in the last month, the daily alcoholic units in the 
last month). 
RESULTS 
Sample characteristics
AUD people characteristics are described in Table 1. 
All recruited AUD people fulfilled the criteria for se-
vere alcohol dependence (8.84 ± 1.99 – mean number 
of DSM-5 positive criteria) as assessed by using DSM-
5 criteria and resulting heavy drinkers according to 
NIAAA (14.38 ± 11.16 – mean number of daily alcohol 
units).
AUD people were compared for gender in all inves-
tigated parameters (see Table 2). Since no statistical 
differences were found between males and females in 
the analysed factors, except, as expected, for the drunk 
alcoholic units (higher in men) and the depression di-
mension of the SCL-90-R (elevated in women), the 
gender factor was not considered in the other reported 
results. 
Dual diagnosis and drinking parameters 
AUD with dual diagnosis and AUD people without 
dual diagnosis did not differ in alcohol consumption 
habits resulting, however, both groups heavy drinkers 
according to the NIAAA criteria (daily alcohol units: 
15.06 ± 11.57 vs 12.79 ± 10.06 and monthly alcohol 
units consumed: 425.94 ± 322.95 vs 365.97 ± 279.43 
respectively). Moreover, AUD with dual diagnosis and 
AUD people without dual diagnosis displayed compa-
rable addiction severity (9.09 ± 2.07 vs 8.18 ± 1.59 - 
mean number of DSM-5 positive criteria).
SCL-90-R scores and SADQ 
Table 3 shows the relationship between the levels of 
dependence measured by SADQ (mild, moderate and 
severe) and the SCL-90-R primary symptoms and the 
GSI. AUD patients with severe dependence had sig-
nificantly higher mean scores in the psychopathological 
SCL-90-R domains. 
Post-hoc tests show that somatization, depression, 
hostility, paranoid ideation, psychoticism, obsessive-
compulsive, interpersonal sensitivity, anxiety and the 
GSI were significantly higher in AUD people with se-
vere and moderate dependence when compared with 
mild dependence (ps < 0.05). Post-hocs also reveal 
differences between moderate and mild addiction in 
somatization, obsessive-compulsive, interpersonal sen-
sitivity, anxiety, hostility and the GSI (ps < 0.05).
SCL- 90-R scores and psychiatric examination 
Table 4 shows the ANOVA data between SCL-90-R 
scores, as dependent variables, and the psychiatric 
examination by a specialist in order to disclose AUD 
people with dual diagnosis and AUD people without a 
dual diagnosis. The results evidence significant differ-
ences between the two groups for each dimension (ps 
< 0.01 in the ANOVA) with the highest values in AUD 
patients with dual diagnosis. 
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Psychiatric examination and SADQ scores
ANOVA considering AUD people with dual diag-
nosis vs AUD people without dual diagnosis and the 
SADQ total score as dependent variable shows that 
AUD patients with dual diagnosis had significantly 
(F(1,244) = 23.101; p < 0.001) higher mean scores of 
total SADQ (25.30 ± 14.25) compared to AUD people 
without dual diagnosis (16.39 ± 10.88 respectively). 
Table 3
SCL-90-R primary symptom dimensions and SADQ dependence levels (mean ± SD). # p < 0.05 Severe vs moderate/mild; § p < 0.05 
moderate vs mild
SCL-90-R Total
SADQ 
n = 245
SADQ
Mild dependence 
(Score range 
0-15)
n = 93
SADQ
Moderate 
dependence
(Score range 
16-30)
n = 88
SADQ
Severe 
dependence 
(Score > 30)
n = 64
F(df) p
Somatization 0.68 ± 0.64 0.49 ± 0.48 0.81 ± 0.70§ 0.76 ± 0.68 6.479(2,244) = 0.002
Obsessive 
compulsive
1.00 ± 0.72 0.78 ± 0.62 1.10 ± 0.77§ 1.18 ± 0.73 7.316(2,244) = 0.001
Interpersonal 
sensitivity
0.68 ± 0.61 0.50 ± 0.49 0.75 ± 0.66§ 0.86 ± 0.65 7.693(2,244) = 0.001
Depression 0.90 ± 0.68 0.73 ± 0.65 0.97 ± 0.72 1.06 ± 0.62 5.431(2,244) = 0.005
Anxiety 0.76 ± 63 0.52 ± 0.53 0.86 ± 66§ 0.97 ± 0.64 12.007(2,244) < 0.001
Hostility 0.54 ± 0.63 0.41 ± 0.55 0.65 ± 0.70§ 0.55 ± 0.63 3.445(2,244) = 0.033
Phobic anxiety 0.35 ± 0.45 0.23 ± 0.35 0.35 ± 0.39 0.52 ± 0.58# 8.414(2,244) < 0.001
Paranoid ideation 0.81 ± 0.67 0.68 ± 0.61 0.83 ± 0.67 0.96 ± 0.72 3.682(2,244) = 0.027
Psychoticism 0.65 ± 0.64 0.50 ± 0.57 0.71 ± 0.62 0.78 ± 0.72 4.485(2,244) = 0.012
GSI 0.76 ± 0.53 0.58 ± 0.46 0.84 ± 0.56§ 0.91 ± 0.53 9.748(2,244) < 0.001
SADQ: severity of alcohol dependence questionnaire; SCL-90-R: symptom check list 90-R.
Table 2
Differences between AUD patients without and with dual diagnosis for gender in self report measures
AUD patient without dual diagnoses AUD patient with dual diagnoses
Men
(n = 58)
Women
(n = 16)
Men
(n = 125)
Women
(n = 46)
DSM 5 severity criteria 8.40 ±1.45 6.50 ± 2.12 9.09 ± 1.77 9.08 ± 2.78
MMSE 15.25 ± 4.74 14.68 ± 3.98 15.56 ± 3.99 15.45 ± 2.63
WAIS 29.80 ± 17.18 32.68±20.35 35.47 ± 14.50 41.98 ± 14.53
SCL-90-R somatization 0.44 ± 0.45 0.50 ± 0.54 0.74 ± 0.67 0.85 ± 0.68
SCL-90-R obsessive compulsive 0.66 ± 0.55 0.58 ± 0.43 1.13 ± 0.72 1.23 ± 0.81
SCL-90-R interpersonal sensitivity 0.44 ± 0.44 0.45 ± 0.54 0.75 ± 0.64 0.90 ± 0.65
SCL-90-R depression 0.56 ± 0.46 0.59 ± 0.56* 0.95 ± 0.63 1.29 ± 0.83*
SCL-90-R anxiety 0.43 ± 0.47 0.54 ± 0.52 0.89 ± 0.64 0.91 ± 0.66
SCL-90-R hostility 0.28 ± 0.40 0.36 ± 0.38 0.63 ± 0.66 0.66 ± 0.77
SCL-90-R phobic anxiety 0.21 ± 0.28 0.23 ± 0.25 0.42 ± 0.51 0.38 ± 0.46
SCL-90-R paranoid ideation 0.52 ± 0.48 0.68 ± 0.68 0.86 ± 0.64 1.07 ± 0.79
SCL-90-R psychoticism 0.38 ± 0.40 0.45 ± 0.47 0.70 ± 0.66 0.89 ± 0.75
SCL-90-R GSI 0.48 ± 0.36 0.52 ± 0.42 0.84 ± 0.53 0.96 ±0.58
SADQ physical withdrawal 3.89 ± 3.27 2.87 ± 3.36 4.83 ± 3.26 5.35 ± 3.40
SADQ affective withdrawal 1.86 ± 2.01 2.81 ± 3.82 3.78 ± 3.37 5.00 ± 4.16
SADQ withdrawal relief drinking 3.62 ± 4.29 2.19 ± 3.85 5.75 ± 4.41 5.24 ± 5.03
SADQ alcohol consumption 4.29 ± 2.31 3.94 ± 2.46 5.60 ± 3.38 4.89 ± 3.34
SADQ rapidity of reinstatement 3.24 ± 2.92 2.63 ± 2.83 5.03 ± 3.46 5.59 ± 3.80
SADQ total 16.93 ± 11.23 14.44 ± 9.58 14.44 ± 9.58 26.04 ± 15.95
SCL-90-R: symptom check list 90-R.
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The emerging finding from the SADQ scales and the 
psychiatric evaluation clearly demonstrates that AUD 
people with dual diagnosis describe themselves affected 
by a more severe alcohol dependence than AUD people 
without a dual diagnosis.
Comparable results were found in the SADQ sub-
scales: patients with dual diagnosis referred to higher 
levels of physical withdrawal (4.97 ± 3.29 vs 3.68 ± 3.29), 
affective withdrawal (4.11 ± 3.63 vs 2.07 ± 2.51), with-
drawal relief drinking (5.61 ± 4.58 vs 3.31 ± 4.23), alcohol 
consumption (5.41 ± 3.38 vs 4.22 ± 2.33), and rapidity of 
reinstatement (5.18 ± 3.55 vs 3.11 ± 2.89) compared to 
AUD patients without dual diagnosis (ps < 0.05). 
SADQ/SCL-90-R and drinking parameters  
(TLFB/LDH)
Figure 1 shows the relationships between the SCL-
90-R, the SADQ and the drinking parameters mea-
sured by TLFB. Indeed, correlations reveal that the 
total score of SADQ positively correlates in all AUD 
patients with the alcoholic units totally consumed (r 
= 0.301; p ≤ 0.001) and the daily alcoholic units con-
sumed in the last month (r = 0.284; p ≤ 0.001) when 
measured by TLFB. No correlations were found with 
the drinking parameters evaluated by LDH. 
Relatively to the SADQ subscales (Figure 2) the corre-
lations demonstrate that the Withdrawal Relief Drinking 
and Alcohol Consumption subscales were significantly 
and positively associated with the alcoholic units totally 
consumed and the alcoholic units consumed daily in the 
last month. No relationship was found between total and 
daily alcoholic units and Affective Withdrawal and Ra-
pidity of Reinstatement subscales. Significant negative 
correlations were observed between SADQ total scores, 
physical withdrawal, alcohol consumption and the age of 
onset of alcohol problems (see plots of Figure 2). No re-
lationship was found between SADQ total scores/SADQ 
subscales with the years of at-risk drinking.
Quite interestingly, no correlations were found be-
tween SCL-90-R and the drinking parameters of the 
TLFB/LDH (alcohol unit/daily, alcohol unit/monthly, 
age of alcohol onset and years of at risk drinking). Fur-
thermore, no evidence was found between psychiatric 
examination and the drinking parameters of the TLFB/
LDH.
SCL-90-R and SADQ subscales
Table 5 indicates the correlation between the symp-
toms’ scales of SCL-90-R and the SADQ subscales. 
Data shows that affective withdrawal, physical with-
drawal and rapidity of reinstatement subscales of 
SADQ were significantly and positively associated with 
the GSI of the SCL-90-R. No relationship was found 
between SADQ alcohol consumption and withdrawal 
relief drinking subscales and GSI. 
DISCUSSION
In the present study, we evaluated the relationship be-
tween the AUD severity and the presence of psychiatric 
comorbidity. Serious AUD patients with dual diagnosis 
are more at-risk of relapse and abandonment of treat-
ment. The psychometric tools used to assess the mag-
nitude of addiction are mainly self-reported interviews, 
Table 4
SCL- 90-R Scores and Psychiatric Examination (mean ± SD)
Psychiatric examination
SCL-90-R Non-psychiatric AUD 
patients 
 n = 74
Psychiatric AUD patients
n = 171
F p
Somatization 0.46 ± 0.47 0.77 ± 0.67 13.599 < 0.001
Obsessive compulsive 0.65 ± 0.52 1.15 ± 0.75 28.758 < 0.001
Interpersonal sensitivity 0.45 ± 0.46 0.79 ± 0.64 17.212 < 0.001
Depression 0.57 ± 0.48 1.04 ± 0.70 27.720 < 0.001
Anxiety 0.45 ± 0.48 0.90 ± 0.65 27.815 < 0.001
Hostility 0.30 ± 0.40 0.64 ± 0.69 15.855 < 0.001
Phobic anxiety 0.21 ± 0.27 0.41 ± 0.49 9.935 = 0.002
Paranoid ideation 0.55 ± 0.53 0.92 ± 0.69 16.011 < 0.001
Psychoticism 0.40 ± 0.41 0.75 ± 0.69 16.877 < 0.001
GSI 0.49 ± 0.37 0.88 ± 0.54 30.975 < 0.001
SCL-90-R: symptom check list 90-R.
non signicant
non signicant
ps < 0.05
ps < 0.05
ps < 0.05
ps < 0.05
Psychiatric
examination
SCL-90-R SADQ 
TLFB alcohol
related 
variables 
Figure 1
Picture illustrating the connections and statistical significance 
between SCL-90-R, SADQ, TLFB alcohol related variables and 
psychiatric examination. 
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with the exception of the severity scale of DSM-5 and 
of the anamnestic instruments based on the frequency 
and the quantities of alcohol consumption, which are 
instead detected by the clinician. In the present investi-
gation, we found that there are no differences between 
AUD people with dual diagnosis and AUD people 
without dual diagnosis based on the amount of alco-
hol drunk and on the severity highlighted by DSM-5. 
Indeed, our patients were all heavy drinkers, however, 
is that despite the dual and non-dual AUD patients do 
not show differences in the alcohol parameters or even 
in the observation of the clinician, dual AUD patients 
report a higher gravity of SADQ dependence.
As highlighted in the results section, we evaluated 
the presence of a psychiatric disorder either through a 
self-report tool, the SCL-90-R, or through a psychiatric 
examination and in both cases AUD patients describe 
themselves as more severe at SADQ. We used the two 
methods because the SCL-90-R, despite being used in 
other studies previously conducted [56, 57], is a screen-
ing questionnaire that identifies the presence of psycho-
logical distress, while obviously, the psychiatric interview 
conducted on the criteria of the DSM-5 allows to the 
clinician to be able to make an affordable diagnosis. 
Although self-report instruments may offer a rapid 
method to collect information, their use also reveals 
certain disadvantages [64]. One is that they are vulner-
able to the consequences of social desirability biases. 
Patients tend to present themselves in a favorable way, 
especially when they are asked to make judgments 
about attitudes and traits that are negatively valued 
[64]. Another self-report instruments’ limit is that they 
necessarily rely on information that is consciously ac-
cessible to the person. This problem, known as the in-
trospective restriction, has a significant impact on the 
information reliability obtained using self-report instru-
ments [65]. Based on these biases, to investigate the 
association between alcohol addiction and psychiatric 
associated diseases, we used other tools as the DSM-
5 criteria by a specialist examination, to further assess 
psychiatric associated disorders and LDH and TLFB 
to assess alcohol consumption. These latest semi-struc-
Table 5
The table shows the correlation between SCL-90-R and SADQ by Pearson’s analysis. Asterisks indicates correlation at 0.05 (*) and 
0.01 (**)
SADQ
physical 
withdrawal
SADQ
affective 
withdrawal
SADQ
withdrawal 
relief drinking
SADQ
alcohol 
consumption
SADQ
rapidity of 
reinstatement
SADQ
total
score
SCL-90-R Somatization 0.204** 0.170** 0.131* 0.187** 0.210** 0.229**
SCL-90-R Obsessive compulsive 0.238** 0.274** 0.141* 0.130* 0.281** 0.270**
SCL-90-R Interpersonal sensitivity 0.183** 0.279** 0.157* 0.133* 0.234** 0.253**
SCL-90-R Depression 0.171** 0.241** 0.131* 0.085 0.222** 0.218**
SCL-90-R Anxiety 0.243** 0.285** 0.232** 0.136* 0.315** 0.314**
SCL-90-R Hostility 0.091 0.073 0.069 0.031 0.160* 0.108
SCL-90-R Phobic anxiety 0.210** 0.232** 0.198** 0.179** 0.230** 0.271**
SCL-90-R Paranoid ideation 0.141* 0.191** 0.116 0.105 0.159* 0.182**
SCL-90-R Psychoticism 0.160* 0.272** 0.103 0.085 0.180** 0.203**
SCL-90-R GSI 0.234** 0.277** 0.177** 0.156* 0.283** 0.288**
SADQ: severity of alcohol dependence questionnaire; SCL-90-R: symptom check list 90-R 
TLFB Alcohol Related 
Variables
Alcohol Unit/die (AU/d)
Alcohol Unit/monthly (AU/m)
Age of Alcohol Onset (AAO) 
Physical
Withdrawal
AU/d: r=0.095
AU/m: r=0.124
AAO: r=-0.182*
Aective
Withdrawal
AU/d: r=0.099
AU/m: r=0.120
AAO: r=-0.125
Withdrawal Relief
Drinking
AU/d: r=0.371**
AU/m: r=0.410**
AAO: r=-0.145
Alcohol
Consumption
AU/d: r=0.274**
AU/m: r=0.278**
AAO: r=-0.304**
Rapidity of 
Reinstatement
AU/d: r=0.109
AU/m: r=0.113
AAO: r=-0.156
SADQ Total Score
AU/d: r=0.268**
AU/m: r=0.297**
AAO: r=0.236**
Figure 2
The figure shows the relationship between TLFB alcohol drinking variables and SADQ subscales. 
** = p < 0.01; * = p < 0.05 
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tured tools have the highest quality to assess alcohol 
consumption using several memory aids to enhance re-
call in which the clinicians have a facilitator role [46, 
66]. Obviously, information on alcohol drinking behav-
ior obtained using TLFB and LDH are not a specific 
measure of dependence severity, but they certainly offer 
crucial information on the nature of patient alcohol be-
havioral relationship [67].
In particular, we found that, by using DSM-5 crite-
ria, AUD people with a positive psychiatrist diagno-
sis, as shown by psychiatrist examination, had higher 
SADQ subscales mean scores compared with AUD 
patients negative to psychopathology. Intriguingly, 
when analyzing the alcohol consumption measured 
by the clinicians (TLFB and LDH), no correlations 
were found between SCL-90-R and alcohol drinking, 
as emerged by TLFB and LDH, and no differences 
were found in drinking habits between patients with 
or without psychiatric associated disorders assessed by 
psychiatric examination because the values of alcohol 
consumption are in AUD people with or without dual 
diagnosis comparable. Data analyzing SADQ and al-
coholic units totally consumed and the daily alcoholic 
units consumed in the last month by TLFB disclosed 
significant correlations. 
Investigating the different dimensions of the depen-
dence levels by SADQ we found that the dimensions 
most closely related to the physical size of addiction 
(physical withdrawal, withdrawal relief drinking and 
alcohol consumption) correlate with the quantities of 
alcohol consumed. However, when we aimed to evalu-
ate the relationship between the SADQ subscales and 
the SCL-90-R scales correlations with the affective 
withdrawal, physical withdrawal and rapidity of rein-
statement scales were revealed. Finally, the association 
between the psychiatric examination and the SADQ 
subscales clearly demonstrates that AUD patients with 
dual diagnosis describe themselves as more affected in 
all dimensions.
To further investigate the relationship between psy-
chiatry, the severity of dependence and alcohol vari-
ables, we considered how the five SADQ subscales 
(physical withdrawal, affective withdrawal, withdrawal 
relief drinking, alcohol consumption, and rapidity of 
reinstatement) were related to SCL-90-R and alco-
hol drinking variables. We found that alcohol drinking 
behavioral variables were significantly and positively 
associated with physical withdrawal and alcohol con-
sumption SADQ subscales and the total SADQ score 
whereas no relationships were found with affective 
withdrawal, withdrawal relief drinking and rapidity of 
reinstatement SADQ subscales. By contrast, affective 
withdrawal, physical withdrawal and relief rapidity of 
reinstatement SADQ subscales correlated with SCL-
90-R GSI while no relationship was found between 
alcohol consumption and withdrawal relief drinking 
SADQ subscales and SCL-90-R GSI.
These findings clearly show that i) the GSI of SCL-
90-R correlates mainly with the affective behavior sub-
scales of SADQ and less with the physical aspects of 
SADQ subscales; ii) intriguingly, the alcoholic units 
consumed by AUD people are mainly linked with the 
physical aspects of SADQ subscales and less with the 
affective behavior subscales; iii) SADQ, although is 
one of the most widely used questionnaires and rec-
ommended by the guidelines, suffers a bias due to the 
patient’s psychiatric conditions. The SADQ specifically 
captures the perception of the severity of addiction that 
in patients with dual diagnosis such perception is em-
phasized and considered more disabling and suffering. 
However, it should be noted that AUD patients with 
a dual diagnosis perceiving a greater amount of stress 
due to their psychopathology feel more dramatically 
the compulsive phase of dependence, while the SADQ 
self-responses differs from the measures obtained by 
the specialist examination where the operator discloses 
the data on consumption without considering the emo-
tional part related to consumption.
Although many environmental, social, genetic, physi-
ological and neurobiological factors have been shown to 
contribute to the gender difference in response to alco-
hol induced damage [68, 69], our study did not disclose 
gross sex differences in behavioral responses. Nonethe-
less, the subject of drinking abuse in women is quite 
significant since women are more sensitive compared 
to men to the harm induced by ethanol [70, 71] and be-
cause women who drink during gestation may stimulate 
a variety of damaging effects to the fetus named Fetal 
Alcohol Spectrum Disorders (FASD) [42, 70-82 as also 
shown in 73, 78, 83-86]. 
CONCLUSION
In conclusion, the strength of the present study is 
that by analyzing 245 AUD patients with or without 
a dual diagnosis, those with dual diagnosis appear to 
emphasize the emotional aspects of their addiction 
based on the SADQ results. Psychiatric comorbidity is 
a crucial issue among patients suffering AUD because 
increases the risk of relapse [87, 88] making more ar-
duous the therapeutic intervention [89-97]. Our data 
suggest that an overestimated self-perception of addic-
tion for alcohol, as measured by SADQ, may represent 
a useful prognostic index to relapse but only for patients 
with dual diagnosis. A careful analysis of the SADQ af-
fective subscales could reveal in AUD people with a 
dual diagnosis a disrupted addiction self-perception, 
information that could be used as a warning signal for 
treating not only dependence per se but, particularly, 
the psychopathological associated diseases to properly 
address pharmacological intervention [98, 99]. 
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